Tuesday, February 27, 2007
But, in the face of extreme suffering and death, how long a trial is long enough? How many people die while the trial is going on? How fast can you get a promising drug on the market to start saving lives, and to start showing a return on the bottom line for the company that developed it? How fast is TOO fast? It’s an awfully fine line, when you think about it.
Learn More. Visit our clinical trials page.
Also, check out Newsweek's related interview of Dr. Jeffrey Peppercorn.
